Navarro SM, Torralbas RFE

Language: Spanish
References: 19
Page: 7056-7064
PDF size: 110.84 Kb.

ABSTRACT

Responsibility for comprehensive preoperative evaluation in ophthalmologic interventions often falls on the surgeon, who should identify those patients with increased cardiovascular risk and take timely measures to prevent these complications. This article focuses on such aspects, defining the actions that correspond directly to the ophthalmologist, those in which he serves as manager, and those which do not concern him rigorously. The most modern pharmacological strategies are also described, with emphasis on the use of antiplatelet drugs or anticoagulants and on the need of antimicrobial prophylaxis; unstable heart entities, which, with few exceptions, require postponing the intervention and treatment principles in the most common cardiovascular diseases are referred.

REFERENCES

1. García Robles JA. Complicaciones cardíacas en la cirugía no cardíaca: una primera aproximación a una población general de bajo riesgo en nuestro entorno. Rev Esp Cardiol. 2006; 59(4): 305-8.

2. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al. Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. J Am Coll Cardiol. 2002; 39(3): 542-53.

3. Fleisher LA, American College of Cardiology/American Heart Association. Cardiac risk stratification for noncardiac surgery: update from the American College of Cardiology/American Heart Association 2007 guidelines. Cleve Clin J Med. 2009; 76(Suppl 4): 9-15.

4. Pastor Torres LF, Antigao Ramírez R, Honorato Pérez JM, Junquera Planas CM, Navarro Salas E, Ortigosa Aso FJ, et al. Guías de práctica clínica de la Sociedad Española de Cardiología en la valoración del riesgo quirúrgico del paciente cardiópata sometido a cirugía no cardíaca. Rev Esp Cardiol. 2001; 54(2): 186-93.

5. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, et al. Stress echocardiography expert consensus statement. Eur J Echocardiogr. 2008; 9(4): 415-37.

6. Kertai MD, Boersma E, Bax JJ, Heijenbrok-Kal MH, Hunink MG, L’Talien GJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart. 2003; 89(11): 1327-34.

7. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis. Lancet. 2008; 372(9654): 1962–76.

8. Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Repaci S, Del Pinto M, et al. Betablockers and risk of all-cause mortality in non-cardiac surgery. Ther Adv Cardiovasc Dis. 2010; 4(2): 109-18.

9. Flach AJ. Importance of discontinuing preoperative systemic alpha-blockers prior to cataract surgery. ARVO. 2010; 2010 May 2-6; Fort Lauderdale, EE.UU. Rockville Pike: Association for Research in Vision and Ophthalmology; 2010.

10. Brown WV. Safety of statins. Curr Opin Lipidol. 2008; 19(6): 558-62.

11. Chen TH, Matyal R. The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery. Semin Cardiothorac Vasc Anesth. 2010; 14(4): 256-73.

12. Eisenberg MJ, Richard PR, Libersan D, Filio KB. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation. 2009; 119(12): 1634-42.

13. Andreotti F, Pafundi T. Los nuevos anticoagulantes y el futuro de la cardiología. Rev Esp Cardiol. 2010; 63(11): 1223-9.

14. Pouya ND, Grand G. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Trans Am Ophthalmol Soc. 2006; 124: 149-60.

15. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, et al. Guía de práctica clínica para la valoración del riesgo cardíaco preoperatorio y el manejo cardíaco perioperatorio en la cirugía no cardíaca. Rev Esp Cardiol. 2009; 62(12): 1467-92.

16. González Treviño JL, Garza Ibarrola JF, García Guerrero J, Cavazos Adame H, Mohamed Hamscho J. Inhibición del reflejo oculocardíaco en pacientes operados de estrabismo con anestesia general con y sin bloqueo subtenon. Rev Mex Oftalmol. 2008; 82(4): 248-50.

17. Chung CJ, Lee JM, Choi SR, Lee SC, Lee JH. Effect of remifentanil on oculocardiac reflex in paediatric strabismus surgery. Acta Anaesthesiol Scand. 2008; 52(9): 1273- 7.

18. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guía de práctica clínica sobre el tratamiento de las valvulopatías. Rev Esp Cardiol. 2007; 60(6): 625-50.

19. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 Guidelines on the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2008; 118: 714-833.